封面
市場調查報告書
商品編碼
1265686

OTC(Over The Counter)試驗的全球市場

Over The Counter (OTC) Testing

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

OTC(Over The Counter)試驗的全球市場在2030年前將達到390億美元

在COVID-19後改變的商務環境中,2022年194億美元的OTC(Over The Counter)試驗的全球市場,在2022年~2030年預計將以年複合成長率9.1%增長,2030年之前達到390億美元。本報告所分析之市場區隔之一的葡萄糖監測試驗年複合成長率將記錄7.7%,到分析期間結束時將達到107億美元。考慮疫情後的復甦,妊娠·不孕檢驗領域今後8年的年複合成長率將修正為9.5%。

美國市場估算為57億美元,中國則將以年複合成長率8.7%增長。

美國的OTC(Over The Counter)試驗市場在2022年估算為達到57億美元。作為世界第2大經濟大國的中國,在2022年~2030年年複合成長率預計將為8.7%,在2030年達到68億美元的市場規模。其他熱門的地區市場有日本和加拿大,在2022年~2030年預計將各以8.3%和8%的速度成長。在歐洲市場中,德國以年複合成長率6.2%成長。

調查對像企業範例

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 全球其他地區

第4章 競爭

簡介目錄
Product Code: MCP22445

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Over The Counter (OTC) Testing Market to Reach $39 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Over The Counter (OTC) Testing estimated at US$19.4 Billion in the year 2022, is projected to reach a revised size of US$39 Billion by 2030, growing at aCAGR of 9.1% over the period 2022-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$10.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Pregnancy & Fertility Tests segment is readjusted to a revised 9.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.7 Billion, While China is Forecast to Grow at 8.7% CAGR

The Over The Counter (OTC) Testing market in the U.S. is estimated at US$5.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 33 Featured) -

  • Abbott Laboratories
  • AccuBioTech
  • ACON Laboratories
  • bioLytical Laboratories
  • i-Health Lab
  • LabStyle Innovations
  • NOWDiagnostics Company
  • OraSure Technologies
  • Roche Diagnostics
  • SD Biosensor
  • Sinocare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Over The Counter (OTC) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Over The Counter (OTC) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Glucose Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Glucose Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pregnancy & Fertility Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Pregnancy & Fertility Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Infectious Disease Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Infectious Disease Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Coagulation Monitoring Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Coagulation Monitoring Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Urinalysis Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Urinalysis Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cholesterol Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cholesterol Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Drugs-of-Abuse Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Drugs-of-Abuse Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Dipsticks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Dipsticks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Lateral Flow Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Lateral Flow Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Over The Counter (OTC) Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • JAPAN
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • CHINA
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • EUROPE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Over The Counter (OTC) Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • FRANCE
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • GERMANY
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Over The Counter (OTC) Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Over The Counter (OTC) Testing by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility Tests, Infectious Disease Tests, Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and Other Test Types for the Years 2014, 2023 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Over The Counter (OTC) Testing by Technology - Immunoassays, Dipsticks and Lateral Flow Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Rest of World 16-Year Perspective for Over The Counter (OTC) Testing by Technology - Percentage Breakdown of Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays for the Years 2014, 2023 & 2030

IV. COMPETITION